| Aug 28 |
2 Must-Buy Medical Stocks With Strong Momentum
|
| Aug 28 |
FDA grants approval to Illumina’s cancer biomarker test with two CDx indications
|
| Aug 28 |
Illumina wins FDA approval for companion diagnostic cancer test
|
| Aug 27 |
FDA approves Illumina's TruSight Oncology biomarker test
|
| Aug 27 |
FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
|
| Aug 26 |
Top Stock Picks for Week of August 26, 2024
|
| Aug 26 |
Is the Options Market Predicting a Spike in Illumina (ILMN) Stock?
|
| Aug 22 |
Bristol Myers' (BMY) HCC Combo Drug Accepted for FDA Review
|
| Aug 21 |
Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe
|
| Aug 21 |
Illumina Sees The Light: GRAIL Is Gone, Focus Restored (Rating Upgrade)
|
